Medifast
MED
240 hedge funds and large institutions have $1.65B invested in Medifast in 2020 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 69 increasing their positions, 91 reducing their positions, and 29 closing their positions.
462% more call options, than puts
Call options by funds: $68M | Put options by funds: $12.1M
55% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 29
7% more funds holding
Funds holding: 224 → 240 (+16)
2% less capital invested
Capital invested by funds: $1.69B → $1.65B (-$37M)
17.74% less ownership
Funds ownership: 103.17% → 85.43% (-18%)
24% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 91
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$30.4M |
| 2 |
Two Sigma Advisers
New York
|
+$17.9M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$15.6M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$13.6M |
| 5 |
Renaissance Technologies
New York
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Engaged Capital
Newport Beach,
California
|
-$147M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$81.3M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$58.2M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$37.9M |
| 5 |
Goldman Sachs
New York
|
-$17.2M |
MED Hedge Fund Activity: Q3 2020 in Review
240 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2020, worth a combined $1.65B — down 2.2% from $1.69B a quarter earlier.
Buyers outnumbered sellers: 45 funds opened new MED positions and 29 closed out — a net gain of 16 holders — while 69 added to existing stakes and 91 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $30.4M. The largest seller was Engaged Capital, cutting an estimated $147M.
- 240 institutional investors held Medifast (MED) as of Q3 2020, up from 224 in Q2 2020.
- Funds reported $1.65B of Medifast stock for Q3 2020, down 2.2% quarter-over-quarter.
- 45 funds opened new Medifast positions in Q3 2020 and 29 closed out, a net change of +16 holders.
- The largest Medifast buyer in Q3 2020 was Two Sigma Investments, an estimated $30.4M added.
- The largest Medifast seller in Q3 2020 was Engaged Capital, an estimated $147M sold.
Based on aggregated 13F filings for Q3 2020.